What's happened
The FDA announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets due to mislabeling errors. The incorrect dosage information poses serious health risks, including life-threatening side effects. Endo Inc. has reported no adverse incidents related to the recall as of November 21, 2024.
Why it matters
What the papers say
According to The Independent, the FDA stated that the mislabeling of clonazepam tablets could lead to "life-threatening" side effects, emphasizing the need for immediate action from consumers and retailers. The NY Post reported that Endo Inc. has not received any reports of adverse effects related to the recalled products, indicating that the recall is a precautionary measure. This proactive approach aims to prevent potential health crises stemming from medication errors.
How we got here
Endo Inc. initially recalled one lot of clonazepam in July 2024 due to mislabeling by a third-party packager. The current recall expands this issue to 16 lots, highlighting ongoing concerns about medication safety and labeling accuracy.
Common question
More on these topics
-
Clonazepam, sold under the brand Klonopin among others, is a medication used to prevent and treat seizures, panic disorder, anxiety, and the movement disorder known as akathisia. It is a tranquilizer of the benzodiazepine class. It is taken by mouth. Effe